StockpollyBeta
Get App
Popularity #2,635
OABI · NASDAQ · Biotechnology

OmniAb (OABI)

Provides antibody-discovery technologies that feed partner drug programs and royalty economics.

$4.92
After hours+0.00 (+0.09%)
At close$4.92(+7.42%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue554841144281413
Cost of revenue500000005861
Gross profit154841144−21813
212626242427232016161619
Research & development141515141313131110141010
788877885777
General & administrative088877880777
Other expenses033246210−403
Operating income−20−21−23−16−20−16−19−16−18−16−8−7
111111103100
Interest income111111100100
Other non-operating income−1−1−1−1−1−1−13−3−100
Income before tax−19−20−22−16−19−15−18−16−15−15−8−6
Income tax expense−3−6−3−2−3−2001000
Net income from continuing operations−16−14−19−14−16−13−18−16−17−14−8−6
Net income−16−14−19−14−16−13−18−16−17−14−8−6
EPS, basic−$0.16−$0.14−$0.19−$0.13−$0.16−$0.12−$0.17−$0.15−$0.14−$0.11−$0.06−$0.05
EPS, diluted−$0.16−$0.14−$0.19−$0.13−$0.16−$0.12−$0.17−$0.15−$0.14−$0.11−$0.06−$0.05
Weighted average shares, basic100100101101102105106106115128128129
Weighted average shares, diluted100100101101102105106106115128128129
EBITDA−14−15−17−9−14−8−14−15−11−7−2−6
Depreciation & amortization555658555860
EBIT−19−20−22−16−19−15−18−19−15−15−8−6